Ranibizumab treatment outcomes in phakic versus pseudophakic eyes: An individual patient data analysis of 2 phase 3 trials

Ophthalmology

Volumn 120, Issue 6, 2013, Pages 1278-1282

  Weinberg, David V ^a   Shapiro, Howard ^b   Ehrlich, Jason S ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VERTEPORFIN;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PHAKIC INTRAOCULAR LENS; PHASE 3 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOPHAKIA; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT OUTCOME; VISION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; LENS, CRYSTALLINE; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PSEUDOPHAKIA; TREATMENT OUTCOME; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84878554365     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.11.042     Document Type: Article

References (11)

1. G.A. Peyman, E.M. Lad, D.M. Moshfeghi Intravitreal injection of therapeutic agents Retina 29 2009 875 912
2. B.E. Klein Is the risk of incidence or progression of age-related macular degeneration increased after cataract surgery? Arch Ophthalmol 127 2009 1528 1529
3. G.J. Harocopos, Y.B. Shui, M. McKinnon Importance of vitreous liquefaction in age-related cataract Invest Ophthalmol Vis Sci 45 2004 77 85
4. D. Hilford, M. Hilford, A. Mathew, P.J. Polkinghorne Posterior vitreous detachment following cataract surgery Eye (Lond) 23 2009 1388 1392
5. A. Mirshahi, F. Hoehn, K. Lorenz, L.O. Hattenbach Incidence of posterior vitreous detachment after cataract surgery J Cataract Refract Surg 35 2009 987 991
6. R.E. Neal, F.A. Bettelheim, C. Lin Alterations in human vitreous humour following cataract extraction Exp Eye Res 80 2005 337 347
7. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
8. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
9. P.K. Kaiser, D.M. Brown, K. Zhang Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results Am J Ophthalmol 144 2007 850 857
10. D.S. Boyer, A.N. Antoszyk, C.C. Awh MARINA Study Group Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 2007 246 252
11. P.J. Rosenfeld, H. Shapiro, J.S. Ehrlich, P. Wong MARINA and ANCHOR Study Groups Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trials Am J Ophthalmol 152 2011 793 798